AU2002217266A1 - Antitumoral carbazoles - Google Patents
Antitumoral carbazolesInfo
- Publication number
- AU2002217266A1 AU2002217266A1 AU2002217266A AU1726602A AU2002217266A1 AU 2002217266 A1 AU2002217266 A1 AU 2002217266A1 AU 2002217266 A AU2002217266 A AU 2002217266A AU 1726602 A AU1726602 A AU 1726602A AU 2002217266 A1 AU2002217266 A1 AU 2002217266A1
- Authority
- AU
- Australia
- Prior art keywords
- optionally substituted
- alkyl
- compound according
- hydroxy
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0030417 | 2000-12-13 | ||
GBGB0030417.0A GB0030417D0 (en) | 2000-12-13 | 2000-12-13 | An anticancer lead compound isolated from a New Zealand ascidian |
PCT/GB2001/005523 WO2002048107A1 (en) | 2000-12-13 | 2001-12-13 | Antitumoral carbazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002217266A1 true AU2002217266A1 (en) | 2002-06-24 |
Family
ID=9905016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002217266A Abandoned AU2002217266A1 (en) | 2000-12-13 | 2001-12-13 | Antitumoral carbazoles |
Country Status (11)
Country | Link |
---|---|
US (1) | US7135494B2 (ja) |
EP (1) | EP1349837A1 (ja) |
JP (1) | JP2004518650A (ja) |
AU (1) | AU2002217266A1 (ja) |
BR (1) | BR0116123A (ja) |
CA (1) | CA2431107A1 (ja) |
GB (1) | GB0030417D0 (ja) |
IL (1) | IL156372A0 (ja) |
MX (1) | MXPA03005374A (ja) |
NZ (1) | NZ526399A (ja) |
WO (1) | WO2002048107A1 (ja) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8530496B2 (en) | 2008-07-08 | 2013-09-10 | Trustees Of Dartmouth College | Compositions and methods for treating cancer |
US8765781B2 (en) | 2008-07-08 | 2014-07-01 | Trustees Of Dartmouth College | Bis-carbazole DNA intercalating agents for antitumor therapy |
US8975274B2 (en) | 2011-09-20 | 2015-03-10 | Trustees Of Dartmouth College | Compositions and methods for treating cancer |
HUE040055T2 (hu) | 2012-09-25 | 2019-02-28 | Chugai Pharmaceutical Co Ltd | RET inhibitor |
WO2015163448A1 (ja) | 2014-04-25 | 2015-10-29 | 中外製薬株式会社 | 4環性化合物を高用量含有する製剤 |
US11077093B2 (en) | 2015-01-16 | 2021-08-03 | Chugai Seiyaku Kabushiki Kaisha | Combination drug |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
TWI825163B (zh) | 2018-09-04 | 2023-12-11 | 日商中外製藥股份有限公司 | 四環性化合物的製造方法 |
WO2023220558A1 (en) * | 2022-05-09 | 2023-11-16 | Institute For Cancer Research D/B/A The Research Institute Of Fox Chase Cancer Center | Combination of curaxins and immune checkpoint inhibitors for treating cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0331257A (ja) | 1989-06-28 | 1991-02-12 | Kissei Pharmaceut Co Ltd | インドール誘導体の製造方法 |
US6194439B1 (en) | 1991-05-29 | 2001-02-27 | Pfizer Inc. | Tricyclic polyhydroxylic tyrosine kinase inhibitors |
JPH08157475A (ja) | 1994-11-29 | 1996-06-18 | Kissei Pharmaceut Co Ltd | 1−ヒドロキシインドール誘導体 |
-
2000
- 2000-12-13 GB GBGB0030417.0A patent/GB0030417D0/en not_active Ceased
-
2001
- 2001-12-13 JP JP2002549638A patent/JP2004518650A/ja active Pending
- 2001-12-13 MX MXPA03005374A patent/MXPA03005374A/es unknown
- 2001-12-13 BR BR0116123-7A patent/BR0116123A/pt not_active IP Right Cessation
- 2001-12-13 IL IL15637201A patent/IL156372A0/xx unknown
- 2001-12-13 US US10/450,594 patent/US7135494B2/en not_active Expired - Fee Related
- 2001-12-13 NZ NZ526399A patent/NZ526399A/en unknown
- 2001-12-13 WO PCT/GB2001/005523 patent/WO2002048107A1/en active IP Right Grant
- 2001-12-13 CA CA002431107A patent/CA2431107A1/en not_active Abandoned
- 2001-12-13 EP EP01270529A patent/EP1349837A1/en not_active Withdrawn
- 2001-12-13 AU AU2002217266A patent/AU2002217266A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA03005374A (es) | 2004-03-26 |
WO2002048107A1 (en) | 2002-06-20 |
BR0116123A (pt) | 2003-10-14 |
US20040072890A1 (en) | 2004-04-15 |
EP1349837A1 (en) | 2003-10-08 |
IL156372A0 (en) | 2004-01-04 |
US7135494B2 (en) | 2006-11-14 |
CA2431107A1 (en) | 2002-06-20 |
GB0030417D0 (en) | 2001-01-24 |
JP2004518650A (ja) | 2004-06-24 |
NZ526399A (en) | 2005-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW442490B (en) | Tricyclic erythromycin derivatives | |
US7135494B2 (en) | Antitumoral carbazoles | |
WO2019238046A1 (zh) | 喜树碱衍生物及其制备方法和应用 | |
JPH11507636A (ja) | 新規なクリプトフィシン | |
EP1399411B1 (en) | Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies | |
CN109796468B (zh) | 大环nannocystin衍生物、及其制备方法和用途 | |
JP2012514041A (ja) | (+)−1,4−ジヒドロ−7−[(3s,4s)−3−メトキシ−4−(メチルアミノ)−1−ピロリジニル]−4−オキソ−1−(2−チアゾリル)−1,8−ナフチリジン−3−カルボン酸の製造方法 | |
WO2018086242A1 (zh) | pH敏感的轴向取代硅酞菁配合物及其制备方法和在医药上的应用 | |
CN113387932B (zh) | 一种诱导brd4蛋白降解的双功能化合物 | |
AU2002258050A1 (en) | Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies | |
JP3776799B2 (ja) | 五環性タキサン化合物 | |
US20230227493A1 (en) | Carboxy substituted glucocorticoid receptor agonists | |
US6403636B1 (en) | Xanthone compounds, their preparation and use as medicament | |
BRPI0617730A2 (pt) | agente para prevenir ou tratar cáncer do páncreas, cáncer de ovário ou cáncer hepático contendo nova pró-fármaco hidrossolúvel | |
US6677456B2 (en) | Pentacyclic taxan compound | |
CN113024557B (zh) | 一种Peganumine A生物碱结构简化物及其应用 | |
AU2001233873B2 (en) | Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity | |
CS195343B2 (en) | Method of producing derivatives of dimere indol-dihydro-indoldiones | |
AU2001233873A1 (en) | Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity | |
US20100256177A1 (en) | Flavopereirine derivatives for cancer therapy | |
KR101567940B1 (ko) | 신규한 광학 활성 (테트라히드로퀴놀린-4-일)말로네이트 유도체 및 이의 항암효과 | |
US20240101585A1 (en) | Heteroaromatic phosphonium salts and their use treating cancer | |
JP2004010565A (ja) | 光線力学的療法剤、抗癌剤、新規なキノキサリン誘導体および医薬組成物 | |
JPH0834789A (ja) | ピロロインドールカルボン酸エステル誘導体及びその製造方法 | |
TW201825510A (zh) | 細胞穿透肽序列 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |